Ftse Mib
37.999,73
-0,80%
DAX
22.567,14
-0,44%
S&P 500
5.521,52
-1,39%
NASDAQ
17.303,01
-1,96%
Bitcoin
81.277,78
0,30%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Crinetics Pharmaceuticals Inc (CRNX) Crinetics Pharmaceuticals Inc (CRNX) Notizie

Crinetics Pharmaceuticals Inc

CRNX
35,04
-0,36 (-1,02%)
13 Mar 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/3/202521:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/3/202521:36GLOBECrinetics Pharmaceuticals Announces March 2025 Inducement..
05/3/202522:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/2/202522:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202522:13EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202522:10EDGAR2Form 8-K - Current report
27/2/202522:05GLOBECrinetics Pharmaceuticals Reports Fourth Quarter and Full..
24/2/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202514:50EDGAR2Form 8-K - Current report
24/2/202514:30GLOBECrinetics Pharmaceuticals Appoints Tobin Schilke as Chief..
20/2/202522:05GLOBECrinetics Pharmaceuticals to Participate in Two Upcoming..
10/2/202522:44GLOBECrinetics Pharmaceuticals Announces February 2025 Inducement..
06/2/202522:35GLOBECrinetics Pharmaceuticals to Report Fourth Quarter and Full..
05/2/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/2/202522:11EDGAR2Form 144 - Report of proposed sale of securities
29/1/202522:30EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
14/1/202523:02EDGAR2Form 8-K - Current report
13/1/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202523:15GLOBECrinetics Pharmaceuticals Announces January 2025 Inducement..
10/1/202513:34EDGAR2Form 8-K - Current report
10/1/202513:00GLOBECrinetics Announces Positive Topline Results From Phase 2..
07/1/202522:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/1/202514:00GLOBECrinetics Pharmaceuticals to Participate in the 43rd Annual..
30/12/202422:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202422:32EDGAR2Form 8-K - Current report
16/12/202414:00GLOBECrinetics Pharmaceuticals Appoints Isabel Kalofonos as Chief..
11/12/202402:44GLOBECrinetics Pharmaceuticals Announces December 2024 Inducement..
09/12/202414:07EDGAR2Form 8-K - Current report
09/12/202414:00GLOBECrinetics Announces FDA Acceptance of New Drug Application..
04/12/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/12/202422:06EDGAR2Form 144 - Report of proposed sale of securities
26/11/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202415:00GLOBECrinetics Pharmaceuticals to Participate in Three Upcoming..
14/11/202422:05GLOBEUPDATE: Crinetics Pharmaceuticals to Showcase Pipeline..
12/11/202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202422:08EDGAR2Form 8-K - Current report
12/11/202422:07GLOBECrinetics Pharmaceuticals to Showcase Pipeline Advancements..
12/11/202422:05GLOBECrinetics Pharmaceuticals Reports Third Quarter 2024..
11/11/202422:05GLOBECrinetics Pharmaceuticals Announces November 2024 Inducement..
16/10/202422:08EDGAR2Form 8-K - Current report
10/10/202422:40GLOBECrinetics Pharmaceuticals Announces October 2024 Inducement..
09/10/202423:13EDGAR2Form 8-K - Current report
09/10/202422:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
09/10/202405:55GLOBECrinetics Pharmaceuticals Announces Pricing of Upsized..
08/10/202423:01EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/10/202422:01GLOBECrinetics Pharmaceuticals Announces Proposed Public Offering..
Apertura: 35,35 Min: 34,40 Max: 36,00
Chiusura: 35,40

La tua Cronologia

NASDAQ
CRNX
Crinetics Pharmaceuticals
LSE
ZR19
Barclays 29
USOTC
PWWBF
Ameritrust Financial Tec... (PK)
USOTC
AQSZF
Aequus Pharmaceuticals (PK)
CSE
TILT
TILT
USOTC
HKPMF
Hokuetsu (PK)
NASDAQ
PEAK
Peak
AMEX
EZM
WisdomTree US MidCap
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci